{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:50:49Z","timestamp":1788958249707,"version":"build-2803163510"},"reference-count":178,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Enfant Cancer Sant\u00e9"},{"name":"Minist\u00e8re de l'enseignement et de la recherche"},{"name":"FHU CAMIn R\u00e9gion Bretagne Manche Leuc\u00e9mie La Vannetaise La Vannetaise"},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ligue contre le cancer Grand-Ouest"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogenesis"],"DOI":"10.1038\/s41389-025-00590-1","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T07:44:28Z","timestamp":1764920668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["CD9, a tetraspanin in cancer: biology and therapeutic promise in acute leukemia"],"prefix":"10.1038","volume":"14","author":[{"given":"Oc\u00e9ane","family":"Gu\u00e9ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Cousin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9mie","family":"Rouger-Gaudichon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Ga\u00eblle","family":"Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1532-5660","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Corre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Gandemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6984-7096","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Mazurier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"590_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1107\/S2053230X1801840X","volume":"75","author":"R Umeda","year":"2019","unstructured":"Umeda R, Nishizawa T, Nureki O. Crystallization of the human tetraspanin protein CD9. Acta Crystallogr Sect F Struct Biol Commun. 2019;75:254.","journal-title":"Acta Crystallogr Sect F Struct Biol Commun"},{"key":"590_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15459-7","volume":"11","author":"R Umeda","year":"2020","unstructured":"Umeda R, Satouh Y, Takemoto M, Nakada-Nakura Y, Liu K, Yokoyama T, et al. Structural insights into tetraspanin CD9 function. Nat Commun. 2020;11:1606.","journal-title":"Nat Commun"},{"key":"590_CR3","doi-asserted-by":"publisher","first-page":"11830","DOI":"10.1073\/pnas.96.21.11830","volume":"96","author":"MS Chen","year":"1999","unstructured":"Chen MS, Tung KS, Coonrod SA, Takahashi Y, Bigler D, Chang A, et al. Role of the integrin-associated protein CD9 in binding between sperm ADAM 2 and the egg integrin alpha6beta1: implications for murine fertilization. Proc Natl Acad Sci USA. 1999;96:11830\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"590_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1126\/science.287.5451.319","volume":"287","author":"F Le Naour","year":"2000","unstructured":"Le Naour F, Rubinstein E, Jasmin C, Prenant M, Boucheix C. Severely reduced female fertility in CD9-deficient mice. Science. 2000;287:319\u201321.","journal-title":"Science"},{"key":"590_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41420-023-01586-9","volume":"9","author":"X Li","year":"2023","unstructured":"Li X, Poire A, Jeong KJ, Zhang D, Chen G, Sun C, et al. Single-cell trajectory analysis reveals a CD9 positive state to contribute to exit from stem cell-like and embryonic diapause states and transit to drug-resistant states. Cell Death Discov. 2023;9:285.","journal-title":"Cell Death Discov"},{"key":"590_CR6","first-page":"3054","volume":"8","author":"J Huan","year":"2015","unstructured":"Huan J, Gao Y, Xu J, Sheng W, Zhu W, Zhang S, et al. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma. Int J Clin Exp Pathol. 2015;8:3054\u201361.","journal-title":"Int J Clin Exp Pathol"},{"key":"590_CR7","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1084\/jem.153.3.726","volume":"153","author":"JH Kersey","year":"1981","unstructured":"Kersey JH, LeBien TW, Abramson CS, Newman R, Sutherland R, Greaves M. P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody. J Exp Med. 1981;153:726\u201331.","journal-title":"J Exp Med"},{"key":"590_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1146\/annurev.cellbio.19.111301.153609","volume":"19","author":"ME Hemler","year":"2003","unstructured":"Hemler ME. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol. 2003;19:397\u2013422.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"590_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/intimm\/5.2.209","volume":"5","author":"MD Wright","year":"1993","unstructured":"Wright MD, Rochelle JM, Tomlinson MG, Seldin MF, Williams AF. Gene structure, chromosomal localization, and protein sequence of mouse CD53 (Cd53): evidence that the transmembrane 4 superfamily arose by gene duplication. Int Immunol. 1993;5:209\u201316.","journal-title":"Int Immunol"},{"key":"590_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0968-0004(02)00014-2","volume":"28","author":"CS Stipp","year":"2003","unstructured":"Stipp CS, Kolesnikova TV, Hemler ME. Functional domains in tetraspanin proteins. Trends Biochem Sci. 2003;28:106\u201312.","journal-title":"Trends Biochem Sci"},{"key":"590_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/srep12201","volume":"5","author":"M Zuidscherwoude","year":"2015","unstructured":"Zuidscherwoude M, G\u00f6ttfert F, Dunlock VME, Figdor CG, van den Bogaart G, van Spriel AB. The tetraspanin web revisited by super-resolution microscopy. Sci Rep. 2015;5:12201.","journal-title":"Sci Rep"},{"key":"590_CR12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1042\/BST20160284","volume":"45","author":"SJ van Deventer","year":"2017","unstructured":"van Deventer SJ, Dunlock VME, van Spriel AB. Molecular interactions shaping the tetraspanin web. Biochem Soc Trans. 2017;45:741\u201350.","journal-title":"Biochem Soc Trans"},{"key":"590_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1042\/BJ20082422","volume":"420","author":"S Charrin","year":"2009","unstructured":"Charrin S, le Naour F, Silvie O, Milhiet PE, Boucheix C, Rubinstein E. Lateral organization of membrane proteins: tetraspanins spin their web. Biochem J. 2009;420:133\u201354.","journal-title":"Biochem J"},{"key":"590_CR14","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3389\/fimmu.2018.00863","volume":"9","author":"R Reyes","year":"2018","unstructured":"Reyes R, Carde\u00f1es B, Machado-Pineda Y, Caba\u00f1as C. Tetraspanin CD9: a key regulator of cell adhesion in the immune system. Front Immunol. 2018;9:863.","journal-title":"Front Immunol"},{"key":"590_CR15","doi-asserted-by":"publisher","first-page":"40545","DOI":"10.1074\/jbc.M107338200","volume":"276","author":"CS Stipp","year":"2001","unstructured":"Stipp CS, Kolesnikova TV, Hemler ME. EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily. J Biol Chem. 2001;276:40545\u201354.","journal-title":"J Biol Chem"},{"key":"590_CR16","doi-asserted-by":"publisher","first-page":"e1030536","DOI":"10.1080\/23723556.2015.1030536","volume":"2","author":"HX Wang","year":"2015","unstructured":"Wang HX, Hemler ME. Novel impact of EWI-2, CD9, and CD81 on TGF-\u03b2 signaling in melanoma. Mol Cell Oncol. 2015;2:e1030536.","journal-title":"Mol Cell Oncol"},{"key":"590_CR17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.tcb.2023.09.003","volume":"34","author":"KJ Susa","year":"2024","unstructured":"Susa KJ, Kruse AC, Blacklow SC. Tetraspanins: structure, dynamics, and principles of partner-protein recognition. Trends Cell Biol. 2024;34:509\u201322.","journal-title":"Trends Cell Biol"},{"key":"590_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00430-020-00687-x","volume":"209","author":"L Florin","year":"2020","unstructured":"Florin L, de Winde CM. Recent advancements in the understanding of tetraspanin functions. Med Microbiol Immunol. 2020;209:393\u20135.","journal-title":"Med Microbiol Immunol"},{"key":"590_CR19","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1172\/JCI81041","volume":"126","author":"CM de Winde","year":"2016","unstructured":"de Winde CM, Veenbergen S, Young KH, Xu-Monette ZY, Wang XX, Xia Y, et al. Tetraspanin CD37 protects against the development of B cell lymphoma. J Clin Investig. 2016;126:653\u201366.","journal-title":"J Clin Investig"},{"key":"590_CR20","doi-asserted-by":"publisher","first-page":"e0171968","DOI":"10.1371\/journal.pone.0171968","volume":"12","author":"IH Salas","year":"2017","unstructured":"Salas IH, Callaerts-Vegh Z, Arranz AM, Guix FX, D\u2019Hooge R, Esteban JA, et al. Tetraspanin 6: a novel regulator of hippocampal synaptic transmission and long term plasticity. PloS One. 2017;12:e0171968.","journal-title":"PloS One"},{"key":"590_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/72829","volume":"24","author":"R Zemni","year":"2000","unstructured":"Zemni R, Bienvenu T, Vinet MC, Sefiani A, Carri\u00e9 A, Billuart P, et al. A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nat Genet. 2000;24:167\u201370.","journal-title":"Nat Genet"},{"key":"590_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7390","volume":"13","author":"M Mrozowska","year":"2024","unstructured":"Mrozowska M, G\u00f3rnicki T, Olbromski M, Party\u0144ska AI, Dzi\u0119giel P, Rusak A. New insights into the role of tetraspanin 6, 7, and 8 in physiology and pathology. Cancer Med. 2024;13:e7390.","journal-title":"Cancer Med"},{"key":"590_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00430-020-00674-2","volume":"209","author":"KA McLaughlin","year":"2020","unstructured":"McLaughlin KA, Tombs MA, Christie MR. Autoimmunity to tetraspanin-7 in type 1 diabetes. Med Microbiol Immunol. 2020;209:437\u201345.","journal-title":"Med Microbiol Immunol"},{"key":"590_CR24","doi-asserted-by":"crossref","unstructured":"Pang S, Luo Z, Dong W, Gao S, Chen W, Liu N, et al. Integrin \u03b21\/FAK\/SRC signal pathway is involved in autism spectrum disorder in Tspan7 knockout rats. Life Sci Alliance. 2023 Mar 1;6. Available from: https:\/\/www.life-science-alliance.org\/content\/6\/3\/e202201616","DOI":"10.26508\/lsa.202201616"},{"key":"590_CR25","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1177\/1535370220981855","volume":"246","author":"A Lorico","year":"2021","unstructured":"Lorico A, Lorico-Rappa M, Karbanov\u00e1 J, Corbeil D, Pizzorno G. CD9, a tetraspanin target for cancer therapy?. Exp Biol Med. 2021;246:1121\u201338.","journal-title":"Exp Biol Med"},{"key":"590_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ydbio.2006.12.041","volume":"304","author":"KE Runge","year":"2007","unstructured":"Runge KE, Evans JE, He ZY, Gupta S, McDonald KL, Stahlberg H, et al. Oocyte CD9 is enriched on the microvillar membrane and required for normal microvillar shape and distribution. Dev Biol. 2007;304:317\u201325.","journal-title":"Dev Biol"},{"key":"590_CR27","doi-asserted-by":"publisher","first-page":"e1006546","DOI":"10.1371\/journal.ppat.1006546","volume":"13","author":"JT Earnest","year":"2017","unstructured":"Earnest JT, Hantak MP, Li K, McCray PB, Perlman S, Gallagher T. The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases. PLoS Pathog. 2017;13:e1006546.","journal-title":"PLoS Pathog"},{"key":"590_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11013-2","volume":"10","author":"H Lazareth","year":"2019","unstructured":"Lazareth H, Henique C, Lenoir O, Puelles VG, Flamant M, Boll\u00e9e G, et al. The tetraspanin CD9 controls migration and proliferation of parietal epithelial cells and glomerular disease progression. Nat Commun. 2019;10:3303.","journal-title":"Nat Commun"},{"key":"590_CR29","first-page":"428","volume":"11","author":"HT Maecker","year":"1997","unstructured":"Maecker HT, Todd SC, Levy S. The tetraspanin superfamily: molecular facilitators. FASEB J Publ Fed Am Soc Exp Biol. 1997;11:428\u201342.","journal-title":"FASEB J Publ Fed Am Soc Exp Biol"},{"key":"590_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrc3640","volume":"14","author":"ME Hemler","year":"2014","unstructured":"Hemler ME. Tetraspanin proteins promote multiple cancer stages. Nat Rev Cancer. 2014;14:49\u201360.","journal-title":"Nat Rev Cancer"},{"key":"590_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/carcin\/bgi209","volume":"27","author":"L Drucker","year":"2006","unstructured":"Drucker L, Tohami T, Tartakover-Matalon S, Zismanov V, Shapiro H, Radnay J, et al. Promoter hypermethylation of tetraspanin members contributes to their silencing in myeloma cell lines. Carcinogenesis. 2006;27:197\u2013204.","journal-title":"Carcinogenesis"},{"key":"590_CR32","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1158\/1078-0432.CCR-07-4489","volume":"14","author":"E De Bruyne","year":"2008","unstructured":"De Bruyne E, Bos TJ, Asosingh K, Vande Broek I, Menu E, Van Valckenborgh E, et al. Epigenetic silencing of the tetraspanin CD9 during disease progression in multiple myeloma cells and correlation with survival. Clin Cancer Res J Am Assoc Cancer Res. 2008;14:2918\u201326.","journal-title":"Clin Cancer Res J Am Assoc Cancer Res"},{"key":"590_CR33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1158\/0008-5472.CAN-07-2531","volume":"68","author":"G Heller","year":"2008","unstructured":"Heller G, Schmidt WM, Ziegler B, Holzer S, M\u00fcllauer L, Bilban M, et al. Genome-wide transcriptional response to 5-aza-2\u2019-deoxycytidine and trichostatin a in multiple myeloma cells. Cancer Res. 2008;68:44\u201354.","journal-title":"Cancer Res"},{"key":"590_CR34","doi-asserted-by":"publisher","first-page":"66344","DOI":"10.18632\/oncotarget.11662","volume":"7","author":"J Fabian","year":"2016","unstructured":"Fabian J, Opitz D, Althoff K, Lodrini M, Hero B, Volland R, et al. MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma. Oncotarget. 2016;7:66344\u201359.","journal-title":"Oncotarget"},{"key":"590_CR35","first-page":"5211","volume":"32","author":"P Kischel","year":"2012","unstructured":"Kischel P, Bellahcene A, Deux B, Lamour V, Dobson R, DE Pauw E, et al. Overexpression of CD9 in human breast cancer cells promotes the development of bone metastases. Anticancer Res. 2012;32:5211\u201320.","journal-title":"Anticancer Res"},{"key":"590_CR36","first-page":"481","volume":"13","author":"F Le Naour","year":"1996","unstructured":"Le Naour F, Prenant M, Francastel C, Rubinstein E, Uzan G, Boucheix C. Transcriptional regulation of the human CD9 gene: characterization of the 5\u2019-flanking region. Oncogene. 1996;13:481\u20136.","journal-title":"Oncogene"},{"key":"590_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-8-385","volume":"8","author":"V Gandemer","year":"2007","unstructured":"Gandemer V, Rio AG, de Tayrac M, Sibut V, Mottier S, Ly Sunnaram B, et al. Five distinct biological processes and 14 differentially expressed genes characterize TEL\/AML1-positive leukemia. BMC Genomics. 2007;8:385.","journal-title":"BMC Genomics"},{"key":"590_CR38","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.leukres.2009.09.033","volume":"34","author":"V Gandemer","year":"2010","unstructured":"Gandemer V, Aubry M, Roussel M, Rio AG, de Tayrac M, Vallee A, et al. CD9 expression can be used to predict childhood TEL\/AML1-positive acute lymphoblastic leukemia: proposal for an accelerated diagnostic flowchart. Leuk Res. 2010;34:430\u20137.","journal-title":"Leuk Res"},{"key":"590_CR39","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.htct.2018.11.007","volume":"41","author":"CB Blunck","year":"2019","unstructured":"Blunck CB, Terra-Granado E, Noronha EP, Wajnberg G, Passetti F, Pombo-de-Oliveira MS, et al. CD9 predicts ETV6-RUNX1 in childhood B-cell precursor acute lymphoblastic leukemia. Hematol Transfus Cell Ther. 2019;41:205\u201311.","journal-title":"Hematol Transfus Cell Ther"},{"key":"590_CR40","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1006\/geno.1993.1150","volume":"16","author":"E Rubinstein","year":"1993","unstructured":"Rubinstein E, Benoit P, Billard M, Plaisance S, Prenant M, Uzan G, et al. Organization of the human CD9 gene. Genomics. 1993;16:132\u20138.","journal-title":"Genomics"},{"key":"590_CR41","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/sj.leu.2400721","volume":"11","author":"F Le Naour","year":"1997","unstructured":"Le Naour F, Francastel C, Prenant M, Lantz O, Boucheix C, Rubinstein E. Upregulation of CD9 expression during TPA treatment of K562 cells. Leukemia. 1997;11:1290\u20137.","journal-title":"Leukemia"},{"key":"590_CR42","first-page":"307","volume":"3","author":"T Magnaldo","year":"1993","unstructured":"Magnaldo T, Vidal RG, Ohtsuki M, Freedberg IM, Blumenberg M. On the role of AP2 in epithelial-specific gene expression. Gene Expr. 1993;3:307\u201315.","journal-title":"Gene Expr"},{"key":"590_CR43","first-page":"3939","volume":"190","author":"AS Cerdeira","year":"2013","unstructured":"Cerdeira AS, Rajakumar A, Royle CM, Lo A, Husain Z, Thadhani RI, et al. Conversion of peripheral blood NK cells to a decidual NK-like phenotype by a cocktail of defined factors. J Immunol Balt Md 1950. 2013;190:3939\u201348.","journal-title":"J Immunol Balt Md 1950"},{"key":"590_CR44","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.3389\/fimmu.2020.01903","volume":"11","author":"LG Hawke","year":"2020","unstructured":"Hawke LG, Whitford MKM, Ormiston ML. The Production of Pro-angiogenic VEGF-A Isoforms by Hypoxic Human NK Cells Is Independent of Their TGF-\u03b2-Mediated Conversion to an ILC1-Like Phenotype. Front Immunol. 2020;11:1903.","journal-title":"Front Immunol"},{"key":"590_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2022.106964","volume":"123","author":"J Rouger-Gaudichon","year":"2022","unstructured":"Rouger-Gaudichon J, Cousin E, Jakobczyk H, Debaize L, Rio AG, Forestier A, et al. Hypoxia regulates CD9 expression and dissemination of B lymphoblasts. Leuk Res. 2022;123:106964.","journal-title":"Leuk Res"},{"key":"590_CR46","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1158\/1078-0432.CCR-06-1692","volume":"13","author":"JC Wang","year":"2007","unstructured":"Wang JC, B\u00e9gin LR, B\u00e9rub\u00e9 NG, Chevalier S, Aprikian AG, Gourdeau H, et al. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications. Clin Cancer Res J Am Assoc Cancer Res. 2007;13:2354\u201361.","journal-title":"Clin Cancer Res J Am Assoc Cancer Res"},{"key":"590_CR47","first-page":"751","volume":"23","author":"M Woegerbauer","year":"2010","unstructured":"Woegerbauer M, Thurnher D, Houben R, Pammer J, Kloimstein P, Heiduschka G, et al. Expression of the tetraspanins CD9, CD37, CD63, and CD151 in Merkel cell carcinoma: strong evidence for a posttranscriptional fine-tuning of CD9 gene expression. Mod Pathol J U S Can Acad Pathol Inc. 2010;23:751\u201362.","journal-title":"Mod Pathol J U S Can Acad Pathol Inc"},{"key":"590_CR48","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.18632\/oncotarget.23118","volume":"9","author":"DR Bond","year":"2018","unstructured":"Bond DR, Naudin C, Carroll AP, Goldie BJ, Brzozowski JS, Jankowski HM, et al. miR-518f-5p decreases tetraspanin CD9 protein levels and differentially affects non-tumourigenic prostate and prostate cancer cell migration and adhesion. Oncotarget. 2018;9:1980\u201391.","journal-title":"Oncotarget"},{"key":"590_CR49","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3390\/cancers12040795","volume":"12","author":"DR Bond","year":"2020","unstructured":"Bond DR, Kahl R, Brzozowski JS, Jankowski H, Naudin C, Pariyar M, et al. Tetraspanin CD9 is regulated by miR-518f-5p and functions in breast cell migration and in vivo tumor growth. Cancers. 2020;12:795.","journal-title":"Cancers"},{"key":"590_CR50","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1128\/MCB.24.2.741-756.2004","volume":"24","author":"L Bruno","year":"2004","unstructured":"Bruno L, Hoffmann R, McBlane F, Brown J, Gupta R, Joshi C, et al. Molecular signatures of self-renewal, differentiation, and lineage choice in multipotential hemopoietic progenitor cells in vitro. Mol Cell Biol. 2004;24:741\u201356.","journal-title":"Mol Cell Biol"},{"key":"590_CR51","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1371\/journal.pgen.0010028","volume":"1","author":"EC Forsberg","year":"2005","unstructured":"Forsberg EC, Prohaska SS, Katzman S, Heffner GC, Stuart JM, Weissman IL. Differential expression of novel potential regulators in hematopoietic stem cells. PLoS Genet. 2005;1:e28.","journal-title":"PLoS Genet"},{"key":"590_CR52","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.celrep.2013.07.020","volume":"4","author":"G Karlsson","year":"2013","unstructured":"Karlsson G, R\u00f6rby E, Pina C, Soneji S, Reckzeh K, Miharada K, et al. The tetraspanin CD9 affords high-purity capture of all murine hematopoietic stem cells. Cell Rep. 2013;4:642\u20138.","journal-title":"Cell Rep"},{"key":"590_CR53","first-page":"2925","volume":"175","author":"A Cariappa","year":"2005","unstructured":"Cariappa A, Shoham T, Liu H, Levy S, Boucheix C, Pillai S. The CD9 tetraspanin is not required for the development of peripheral B cells or for humoral immunity. J Immunol Balt Md 1950. 2005;175:2925\u201330.","journal-title":"J Immunol Balt Md 1950"},{"key":"590_CR54","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1182\/blood.V97.7.1982","volume":"97","author":"D Clay","year":"2001","unstructured":"Clay D, Rubinstein E, Mishal Z, Anjo A, Prenant M, Jasmin C, et al. CD9 and megakaryocyte differentiation. Blood. 2001;97:1982\u20139.","journal-title":"Blood"},{"key":"590_CR55","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1182\/blood-2010-04-281329","volume":"117","author":"KT Leung","year":"2011","unstructured":"Leung KT, Chan KYY, Ng PC, Lau TK, Chiu WM, Tsang KS, et al. The tetraspanin CD9 regulates migration, adhesion, and homing of human cord blood CD34+ hematopoietic stem and progenitor cells. Blood. 2011;117:1840\u201350.","journal-title":"Blood"},{"key":"590_CR56","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/cam4.2007","volume":"8","author":"L Touzet","year":"2019","unstructured":"Touzet L, Dumezy F, Roumier C, Berthon C, Bories C, Quesnel B, et al. CD9 in acute myeloid leukemia: prognostic role and usefulness to target leukemic stem cells. Cancer Med. 2019;8:1279\u201388.","journal-title":"Cancer Med"},{"key":"590_CR57","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13287-021-02155-6","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wang G, Zhang J, Chen X, Xu H, Heng G, et al. CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia. Stem Cell Res Ther. 2021;12:86.","journal-title":"Stem Cell Res Ther"},{"key":"590_CR58","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6391264","volume":"2016","author":"LH Pugholm","year":"2016","unstructured":"Pugholm LH, B\u00e6k R, S\u00f8ndergaard EKL, Revenfeld ALS, J\u00f8rgensen MM, Varming K. Phenotyping of leukocytes and leukocyte-derived extracellular vesicles. J Immunol Res. 2016;2016:6391264.","journal-title":"J Immunol Res"},{"key":"590_CR59","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1399-0039.2004.00271.x","volume":"64","author":"T Tohami","year":"2004","unstructured":"Tohami T, Drucker L, Radnay J, Shapira H, Lishner M. Expression of tetraspanins in peripheral blood leukocytes: a comparison between normal and infectious conditions. Tissue Antigens. 2004;64:235\u201342.","journal-title":"Tissue Antigens"},{"key":"590_CR60","first-page":"201","volume":"30","author":"C Boucheix","year":"1988","unstructured":"Boucheix C, Benoit P. CD9 antigen: will platelet physiology help to explain the function of a surface molecule during hemopoietic differentiation?. Nouv Rev Fr Hematol. 1988;30:201\u20132.","journal-title":"Nouv Rev Fr Hematol"},{"key":"590_CR61","doi-asserted-by":"publisher","first-page":"12289","DOI":"10.1016\/S0021-9258(18)63856-6","volume":"264","author":"JR Slupsky","year":"1989","unstructured":"Slupsky JR, Seehafer JG, Tang SC, Masellis-Smith A, Shaw AR. Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb-IIIa complex. J Biol Chem. 1989;264:12289\u201393. Jul 25.","journal-title":"J Biol Chem"},{"key":"590_CR62","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1023\/A:1026437522882","volume":"29","author":"C Brisson","year":"1997","unstructured":"Brisson C, Azorsa DO, Jennings LK, Moog S, Cazenave JP, Lanza F. Co-localization of CD9 and GPIIb-IIIa (alpha IIb beta 3 integrin) on activated platelet pseudopods and alpha-granule membranes. Histochem J. 1997;29:153\u201365.","journal-title":"Histochem J"},{"key":"590_CR63","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/0006-291X(91)91384-O","volume":"179","author":"JG Seehafer","year":"1991","unstructured":"Seehafer JG, Shaw AR. Evidence that the signal-initiating membrane protein CD9 is associated with small GTP-binding proteins. Biochem Biophys Res Commun. 1991;179:401\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"590_CR64","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1182\/blood.V78.7.1753.1753","volume":"78","author":"L Griffith","year":"1991","unstructured":"Griffith L, Slupsky J, Seehafer J, Boshkov L, Shaw AR. Platelet activation by immobilized monoclonal antibody: evidence for a CD9 proximal signal. Blood. 1991;78:1753\u20139.","journal-title":"Blood"},{"key":"590_CR65","doi-asserted-by":"publisher","first-page":"e0153860","DOI":"10.1371\/journal.pone.0153860","volume":"11","author":"M Weiss-Gayet","year":"2016","unstructured":"Weiss-Gayet M, Starck J, Chaabouni A, Chazaud B, Morl\u00e9 F. Notch stimulates both self-renewal and lineage plasticity in a subset of murine CD9high committed megakaryocytic progenitors. PLoS ONE. 2016;11:e0153860.","journal-title":"PLoS ONE"},{"key":"590_CR66","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1182\/blood.V112.11.891.891","volume":"112","author":"T Kono","year":"2008","unstructured":"Kono T, Mukai H, Kozuma Y, Kojima H, Ninomiya H. Functional Analysis of CD9 during Megakaryopoiesis. Blood. 2008;112:891.","journal-title":"Blood"},{"key":"590_CR67","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/sj.leu.2403822","volume":"19","author":"S Barrena","year":"2005","unstructured":"Barrena S, Almeida J, Yunta M, L\u00f3pez A, Fern\u00e1ndez-Mosteir\u00edn N, Giralt M, et al. Aberrant expression of tetraspanin molecules in B-cell chronic lymphoproliferative disorders and its correlation with normal B-cell maturation. Leukemia. 2005;19:1376\u201383.","journal-title":"Leukemia"},{"key":"590_CR68","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1182\/blood.V93.8.2586","volume":"93","author":"K Aoyama","year":"1999","unstructured":"Aoyama K, Oritani K, Yokota T, Ishikawa J, Nishiura T, Miyake K, et al. Stromal cell CD9 regulates differentiation of hematopoietic stem\/progenitor cells. Blood. 1999;93:2586\u201394.","journal-title":"Blood"},{"key":"590_CR69","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3109\/10428190009087017","volume":"38","author":"S Hayashi","year":"2000","unstructured":"Hayashi S, Miyake K, Kincade PW. The CD9 molecule on stromal cells. Leuk Lymphoma. 2000;38:265\u201370.","journal-title":"Leuk Lymphoma"},{"key":"590_CR70","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3109\/10428190009060328","volume":"38","author":"K Oritani","year":"2000","unstructured":"Oritani K, Aoyama K, Tomiyama Y, Kincade PW, Matsuzawa Y. Stromal cell CD9 and the differentiation of hematopoietic stem\/progenitor cells. Leuk Lymphoma. 2000;38:147\u201352.","journal-title":"Leuk Lymphoma"},{"key":"590_CR71","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1042\/EBC20190012","volume":"63","author":"JRW Conway","year":"2019","unstructured":"Conway JRW, Jacquemet G. Cell matrix adhesion in cell migration. Essays Biochem. 2019;63:535\u201351.","journal-title":"Essays Biochem"},{"key":"590_CR72","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1083\/jcb.200805076","volume":"183","author":"O Barreiro","year":"2008","unstructured":"Barreiro O, Zamai M, Y\u00e1\u00f1ez-M\u00f3 M, Tejera E, L\u00f3pez-Romero P, Monk PN, et al. Endothelial adhesion receptors are recruited to adherent leukocytes by inclusion in preformed tetraspanin nanoplatforms. J Cell Biol. 2008;183:527.","journal-title":"J Cell Biol"},{"key":"590_CR73","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1182\/blood-2004-09-3606","volume":"105","author":"O Barreiro","year":"2005","unstructured":"Barreiro O, Y\u00e1\u00f1ez-M\u00f3 M, Sala-Vald\u00e9s M, Guti\u00e9rrez-L\u00f3pez MD, Ovalle S, Higginbottom A, et al. Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation. Blood. 2005;105:2852\u201361.","journal-title":"Blood"},{"key":"590_CR74","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00018-012-1132-0","volume":"70","author":"A Gilsanz","year":"2013","unstructured":"Gilsanz A, S\u00e1nchez-Mart\u00edn L, Guti\u00e9rrez-L\u00f3pez MD, Ovalle S, Machado-Pineda Y, Reyes R, et al. ALCAM\/CD166 adhesive function is regulated by the tetraspanin CD9. Cell Mol Life Sci CMLS. 2013;70:475\u201393.","journal-title":"Cell Mol Life Sci CMLS"},{"key":"590_CR75","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/eji.201344235","volume":"44","author":"V Rocha-Perugini","year":"2014","unstructured":"Rocha-Perugini V, Gonz\u00e1lez-Granado JM, Tejera E, L\u00f3pez-Mart\u00edn S, Ya\u00f1ez-M\u00f3 M, S\u00e1nchez-Madrid F. Tetraspanins CD9 and CD151 at the immune synapse support T-cell integrin signaling. Eur J Immunol. 2014;44:1967\u201375.","journal-title":"Eur J Immunol"},{"key":"590_CR76","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1006\/excr.1999.4596","volume":"251","author":"GA Cook","year":"1999","unstructured":"Cook GA, Wilkinson DA, Crossno JT, Raghow R, Jennings LK. The tetraspanin CD9 influences the adhesion, spreading, and pericellular fibronectin matrix assembly of Chinese hamster ovary cells on human plasma fibronectin. Exp Cell Res. 1999;251:356\u201371.","journal-title":"Exp Cell Res"},{"key":"590_CR77","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1242\/jcs.058875","volume":"123","author":"L Cailleteau","year":"2010","unstructured":"Cailleteau L, Estrach S, Thyss R, Boyer L, Doye A, Domange B, et al. alpha2beta1 integrin controls association of Rac with the membrane and triggers quiescence of endothelial cells. J Cell Sci. 2010;123:2491\u2013501.","journal-title":"J Cell Sci"},{"key":"590_CR78","first-page":"2768","volume":"152","author":"A Masellis-Smith","year":"1994","unstructured":"Masellis-Smith A, Shaw AR. CD9-regulated adhesion. Anti-CD9 monoclonal antibody induce pre-B cell adhesion to bone marrow fibroblasts through de novo recognition of fibronectin. J Immunol Balt Md 1950. 1994;152:2768\u201377.","journal-title":"J Immunol Balt Md 1950"},{"key":"590_CR79","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1007\/s00018-011-0639-0","volume":"68","author":"MD Guti\u00e9rrez-L\u00f3pez","year":"2011","unstructured":"Guti\u00e9rrez-L\u00f3pez MD, Gilsanz A, Y\u00e1\u00f1ez-M\u00f3 M, Ovalle S, Lafuente EM, Dom\u00ednguez C, et al. The sheddase activity of ADAM17\/TACE is regulated by the tetraspanin CD9. Cell Mol Life Sci CMLS. 2011;68:3275\u201392.","journal-title":"Cell Mol Life Sci CMLS"},{"key":"590_CR80","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1042\/BST0390541","volume":"39","author":"M Y\u00e1\u00f1ez-M\u00f3","year":"2011","unstructured":"Y\u00e1\u00f1ez-M\u00f3 M, S\u00e1nchez-Madrid F, Caba\u00f1as C. Membrane proteases and tetraspanins. Biochem Soc Trans. 2011;39:541\u20136.","journal-title":"Biochem Soc Trans"},{"key":"590_CR81","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fnmol.2016.00149","volume":"9","author":"L Seipold","year":"2016","unstructured":"Seipold L, Saftig P. The emerging role of tetraspanins in the proteolytic processing of the amyloid precursor protein. Front Mol Neurosci. 2016;9:149.","journal-title":"Front Mol Neurosci"},{"key":"590_CR82","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11010-010-0685-1","volume":"350","author":"S Chen","year":"2011","unstructured":"Chen S, Sun Y, Jin Z, Jing X. Functional and biochemical studies of CD9 in fibrosarcoma cell line. Mol Cell Biochem. 2011;350:89\u201399.","journal-title":"Mol Cell Biochem"},{"key":"590_CR83","doi-asserted-by":"publisher","first-page":"9557","DOI":"10.1158\/0008-5472.CAN-06-1131","volume":"66","author":"Y Saito","year":"2006","unstructured":"Saito Y, Tachibana I, Takeda Y, Yamane H, He P, Suzuki M, et al. Absence of CD9 enhances adhesion-dependent morphologic differentiation, survival, and matrix metalloproteinase-2 production in small cell lung cancer cells. Cancer Res. 2006;66:9557\u201365.","journal-title":"Cancer Res"},{"key":"590_CR84","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1002\/ijc.22902","volume":"121","author":"S Ovalle","year":"2007","unstructured":"Ovalle S, Guti\u00e9rrez-L\u00f3pez MD, Olmo N, Turnay J, Lizarbe MA, Majano P, et al. The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells. Int J Cancer. 2007;121:2140\u201352.","journal-title":"Int J Cancer"},{"key":"590_CR85","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/carcin\/bgr257","volume":"33","author":"JR Hwang","year":"2012","unstructured":"Hwang JR, Jo K, Lee Y, Sung BJ, Park YW, Lee JH. Upregulation of CD9 in ovarian cancer is related to the induction of TNF-\u03b1 gene expression and constitutive NF-\u03baB activation. Carcinogenesis. 2012;33:77\u201383.","journal-title":"Carcinogenesis"},{"key":"590_CR86","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1182\/blood-2015-02-628560","volume":"126","author":"MP Arnaud","year":"2015","unstructured":"Arnaud MP, Vall\u00e9e A, Robert G, Bonneau J, Leroy C, Varin-Blank N, et al. CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling. Blood. 2015;126:1802\u201312.","journal-title":"Blood"},{"key":"590_CR87","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jss.2004.01.014","volume":"117","author":"H Hori","year":"2004","unstructured":"Hori H, Yano S, Koufuji K, Takeda J, Shirouzu K. CD9 expression in gastric cancer and its significance. J Surg Res. 2004;117:208\u201315.","journal-title":"J Surg Res"},{"key":"590_CR88","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.3389\/fimmu.2018.02316","volume":"9","author":"C Brosseau","year":"2018","unstructured":"Brosseau C, Colas L, Magnan A, Brouard S. CD9 tetraspanin: a new pathway for the regulation of inflammation?. Front Immunol. 2018;9:2316.","journal-title":"Front Immunol"},{"key":"590_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1140738","volume":"13","author":"R Ondru\u0161\u0161ek","year":"2023","unstructured":"Ondru\u0161\u0161ek R, Kvoka\u010dkov\u00e1 B, Kry\u0161tofov\u00e1 K, Brychtov\u00e1 S, Sou\u010dek K, Bouchal J. Prognostic value and multifaceted roles of tetraspanin CD9 in cancer. Front Oncol. 2023;13:1140738.","journal-title":"Front Oncol"},{"key":"590_CR90","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1111\/his.13184","volume":"70","author":"HJ Kwon","year":"2017","unstructured":"Kwon HJ, Choi JE, Kang SH, Son Y, Bae YK. Prognostic significance of CD9 expression differs between tumour cells and stromal immune cells, and depends on the molecular subtype of the invasive breast carcinoma. Histopathology. 2017;70:1155\u201365.","journal-title":"Histopathology"},{"key":"590_CR91","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41556-019-0407-1","volume":"21","author":"VMY Wang","year":"2019","unstructured":"Wang VMY, Ferreira RMM, Almagro J, Evan T, Legrave N, Zaw Thin M, et al. CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth. Nat Cell Biol. 2019;21:1425\u201335.","journal-title":"Nat Cell Biol"},{"key":"590_CR92","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4048\/jbc.2019.22.e9","volume":"22","author":"J Baek","year":"2019","unstructured":"Baek J, Jang N, Choi JE, Kim JR, Bae YK. CD9 expression in tumor cells is associated with poor prognosis in patients with invasive lobular carcinoma. J Breast Cancer. 2019;22:77\u201385.","journal-title":"J Breast Cancer"},{"key":"590_CR93","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nrc2543","volume":"9","author":"M Z\u00f6ller","year":"2009","unstructured":"Z\u00f6ller M. Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer. 2009;9:40\u201355.","journal-title":"Nat Rev Cancer"},{"key":"590_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115705","volume":"215","author":"N Tosic","year":"2023","unstructured":"Tosic N, Marjanovic I, Lazic J. Pediatric acute myeloid leukemia: Insight into genetic landscape and novel targeted approaches. Biochem Pharm. 2023;215:115705.","journal-title":"Biochem Pharm"},{"key":"590_CR95","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.3390\/cancers15143583","volume":"15","author":"RJ Marrero","year":"2023","unstructured":"Marrero RJ, Lamba JK. Current landscape of genome-wide association studies in acute myeloid leukemia: a review. Cancers. 2023;15:3583.","journal-title":"Cancers"},{"key":"590_CR96","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.blre.2019.04.003","volume":"36","author":"J Gaudichon","year":"2019","unstructured":"Gaudichon J, Jakobczyk H, Debaize L, Cousin E, Galibert MD, Troadec MB, et al. Mechanisms of extramedullary relapse in acute lymphoblastic leukemia: reconciling biological concepts and clinical issues. Blood Rev. 2019;36:40\u201356.","journal-title":"Blood Rev"},{"key":"590_CR97","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41375-023-02089-3","volume":"38","author":"KT Leung","year":"2024","unstructured":"Leung KT, Cai J, Liu Y, Chan KYY, Shao J, Yang H, et al. Prognostic implications of CD9 in childhood acute lymphoblastic leukemia: insights from a nationwide multicenter study in China. Leukemia. 2024;38:250\u20137.","journal-title":"Leukemia"},{"key":"590_CR98","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1038\/sj.leu.2401177","volume":"12","author":"MJ Borowitz","year":"1998","unstructured":"Borowitz MJ, Rubnitz J, Nash M, Pullen DJ, Camitta B. Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study. Leukemia. 1998;12:1764\u201370.","journal-title":"Leukemia"},{"key":"590_CR99","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3233\/CBM-170422","volume":"21","author":"P Liang","year":"2018","unstructured":"Liang P, Miao M, Liu Z, Wang H, Jiang W, Ma S, et al. CD9 expression indicates a poor outcome in acute lymphoblastic leukemia. Cancer Biomark Sect Dis Markers. 2018;21:781\u20136.","journal-title":"Cancer Biomark Sect Dis Markers"},{"key":"590_CR100","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.leukres.2004.11.027","volume":"29","author":"B Ly-Sunnaram","year":"2005","unstructured":"Ly-Sunnaram B, Henry C, Gandemer V, Mee FL, Burtin F, Blayau M, et al. Late ovarian relapse of TEL\/AML1 positive ALL confirming that TEL deletion is a secondary event in leukemogenesis. Leuk Res. 2005;29:1089\u201394.","journal-title":"Leuk Res"},{"key":"590_CR101","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/ijlh.12929","volume":"41","author":"F Ren","year":"2019","unstructured":"Ren F, Zhang N, Xu Z, Xu J, Zhang Y, Chen X, et al. The CD9+CD11b- HLA-DR- immunophenotype can be used to diagnose acute promyelocytic leukemia. Int J Lab Hematol. 2019;41:168\u201375.","journal-title":"Int J Lab Hematol"},{"key":"590_CR102","first-page":"287","volume":"37","author":"ES Satlsar","year":"2020","unstructured":"Satlsar ES, Mosleh M, Mehrpouri M. CD9 is a very helpful marker for discriminating AML-M3 from HLA-DR-negative non-M3 AML. Turk J Haematol J Turk Soc Haematol. 2020;37:287\u20139.","journal-title":"Turk J Haematol J Turk Soc Haematol"},{"key":"590_CR103","doi-asserted-by":"crossref","unstructured":"Wen Z, Xue X, Li S, Liu Y, Jin Y, Jiang N, et al. Measurable residual disease analysis by flow cytometry and correlation with molecular measurable residual disease in acute promyelocytic leukemia: a real-world prospective study. Arch Pathol Lab Med. 2024;49:262\u2013270.","DOI":"10.5858\/arpa.2023-0460-OA"},{"key":"590_CR104","doi-asserted-by":"publisher","first-page":"e98561","DOI":"10.1172\/jci.insight.98561","volume":"3","author":"E Coustan-Smith","year":"2018","unstructured":"Coustan-Smith E, Song G, Shurtleff S, Yeoh AEJ, Chng WJ, Chen SP, et al. Universal monitoring of minimal residual disease in acute myeloid leukemia. JCI Insight. 2018;3:e98561.","journal-title":"JCI Insight"},{"key":"590_CR105","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbrc.2009.02.123","volume":"382","author":"H Nishida","year":"2009","unstructured":"Nishida H, Yamazaki H, Yamada T, Iwata S, Dang NH, Inukai T, et al. CD9 correlates with cancer stem cell potentials in human B-acute lymphoblastic leukemia cells. Biochem Biophys Res Commun. 2009;382:57\u201362.","journal-title":"Biochem Biophys Res Commun"},{"key":"590_CR106","first-page":"249","volume":"9","author":"X Thomas","year":"1995","unstructured":"Thomas X, Archimbaud E, Charrin C, Magaud JP, Fiere D. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia. Leukemia. 1995;9:249\u201353. Feb.","journal-title":"Leukemia"},{"key":"590_CR107","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbrc.2011.04.098","volume":"409","author":"H Yamazaki","year":"2011","unstructured":"Yamazaki H, Wilson Xu C, Naito M, Nishida H, Okamoto T, Ghani FI, et al. Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia. Biochem Biophys Res Commun. 2011;409:14\u201321.","journal-title":"Biochem Biophys Res Commun"},{"key":"590_CR108","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41375-018-0180-3","volume":"33","author":"S Haubner","year":"2019","unstructured":"Haubner S, Perna F, K\u00f6hnke T, Schmidt C, Berman S, Augsberger C, et al. Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML. Leukemia. 2019;33:64\u201374.","journal-title":"Leukemia"},{"key":"590_CR109","first-page":"594","volume":"15","author":"M Wang","year":"2019","unstructured":"Wang M. CD9 boosts PEC glomerular invasion. Nat Rev Nephrol. 2019;15:594\u2013594.","journal-title":"Nat Rev Nephrol"},{"key":"590_CR110","doi-asserted-by":"publisher","first-page":"7970","DOI":"10.18632\/oncotarget.3419","volume":"6","author":"G Rappa","year":"2015","unstructured":"Rappa G, Green TM, Karbanov\u00e1 J, Corbeil D, Lorico A. Tetraspanin CD9 determines invasiveness and tumorigenicity of human breast cancer cells. Oncotarget. 2015;6:7970\u201391.","journal-title":"Oncotarget"},{"key":"590_CR111","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/bjc.2017.497","volume":"118","author":"J Rem\u0161\u00edk","year":"2018","unstructured":"Rem\u0161\u00edk J, Fedr R, Navr\u00e1til J, Bin\u00f3 L, Slab\u00e1kov\u00e1 E, Fabian P, et al. Plasticity and intratumoural heterogeneity of cell surface antigen expression in breast cancer. Br J Cancer. 2018;118:813\u20139.","journal-title":"Br J Cancer"},{"key":"590_CR112","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3892\/or.2021.8091","volume":"46","author":"YF Shi","year":"2021","unstructured":"Shi YF, Huang ZY, Huang YS, Dong RJ, Xing CY, Yu K, et al. Interaction between CD9 and PI3K\u2011p85 activates the PI3K\/AKT signaling pathway in B\u2011lineage acute lymphoblastic leukemia. Oncol Rep. 2021;46:140.","journal-title":"Oncol Rep"},{"key":"590_CR113","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","volume":"296","author":"LC Cantley","year":"2002","unstructured":"Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296:1655\u20137.","journal-title":"Science"},{"key":"590_CR114","first-page":"9097","volume":"8","author":"L Zhang","year":"2015","unstructured":"Zhang L, Zhu S, Shi X, Sha W. The silence of p66(Shc) in HCT8 cells inhibits the viability via PI3K\/AKT\/Mdm-2\/p53 signaling pathway. Int J Clin Exp Pathol. 2015;8:9097\u2013104.","journal-title":"Int J Clin Exp Pathol"},{"key":"590_CR115","doi-asserted-by":"crossref","unstructured":"Xing C, Xu W, Shi Y, Zhou B, Wu D, Liang B, et al. CD9 knockdown suppresses cell proliferation, adhesion, migration and invasion, while promoting apoptosis and the efficacy of chemotherapeutic drugs and imatinib in Ph+ ALL SUP\u2011B15 cells. Mol Med Rep. 2020;22:2791\u2013800.","DOI":"10.3892\/mmr.2020.11350"},{"key":"590_CR116","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1084\/jem.177.5.1231","volume":"177","author":"S Ikeyama","year":"1993","unstructured":"Ikeyama S, Koyama M, Yamaoko M, Sasada R, Miyake M. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1\/CD9) DNA. J Exp Med. 1993;177:1231\u20137.","journal-title":"J Exp Med"},{"key":"590_CR117","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/emm.2005.31","volume":"37","author":"IK Hong","year":"2005","unstructured":"Hong IK, Kim YM, Jeoung DI, Kim KC, Lee H. Tetraspanin CD9 induces MMP-2 expression by activating p38 MAPK, JNK and c-Jun pathways in human melanoma cells. Exp Mol Med. 2005;37:230\u20139.","journal-title":"Exp Mol Med"},{"key":"590_CR118","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.cyto.2018.05.038","volume":"111","author":"DJ Blake","year":"2018","unstructured":"Blake DJ, Martiszus JD, Lone TH, Fenster SD. Ablation of the CD9 receptor in human lung cancer cells using CRISPR\/Cas alters migration to chemoattractants including IL-16. Cytokine. 2018;111:567\u201370.","journal-title":"Cytokine"},{"key":"590_CR119","doi-asserted-by":"publisher","first-page":"24092","DOI":"10.1074\/jbc.270.41.24092","volume":"270","author":"AR Shaw","year":"1995","unstructured":"Shaw AR, Domanska A, Mak A, Gilchrist A, Dobler K, Visser L, et al. Ectopic expression of human and feline CD9 in a human B cell line confers beta 1 integrin-dependent motility on fibronectin and laminin substrates and enhanced tyrosine phosphorylation. J Biol Chem. 1995;270:24092\u20139.","journal-title":"J Biol Chem"},{"key":"590_CR120","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1042\/BST0390563","volume":"39","author":"D Powner","year":"2011","unstructured":"Powner D, Kopp PM, Monkley SJ, Critchley DR, Berditchevski F. Tetraspanin CD9 in cell migration. Biochem Soc Trans. 2011;39:563\u20137.","journal-title":"Biochem Soc Trans"},{"key":"590_CR121","first-page":"6485","volume":"182","author":"M Suzuki","year":"2009","unstructured":"Suzuki M, Tachibana I, Takeda Y, He P, Minami S, Iwasaki T, et al. Tetraspanin CD9 negatively regulates lipopolysaccharide-induced macrophage activation and lung inflammation. J Immunol Balt Md 1950. 2009;182:6485\u201393.","journal-title":"J Immunol Balt Md 1950"},{"key":"590_CR122","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1091\/mbc.e08-11-1149","volume":"20","author":"MA Lafleur","year":"2009","unstructured":"Lafleur MA, Xu D, Hemler ME. Tetraspanin proteins regulate membrane type-1 matrix metalloproteinase-dependent pericellular proteolysis. Mol Biol Cell. 2009;20:2030\u201340.","journal-title":"Mol Biol Cell"},{"key":"590_CR123","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41375-019-0593-7","volume":"34","author":"KT Leung","year":"2020","unstructured":"Leung KT, Zhang C, Chan KYY, Li K, Cheung JTK, Ng MHL, et al. CD9 blockade suppresses disease progression of high-risk pediatric B-cell precursor acute lymphoblastic leukemia and enhances chemosensitivity. Leukemia. 2020;34:709\u201320.","journal-title":"Leukemia"},{"key":"590_CR124","first-page":"2833","volume":"109","author":"C Zhang","year":"2024","unstructured":"Zhang C, Chan KYY, Ng WH, Cheung JTK, Sun Q, Wang H, et al. CD9 shapes glucocorticoid sensitivity in pediatric B-cell precursor acute lymphoblastic leukemia. Haematologica. 2024;109:2833.","journal-title":"Haematologica"},{"key":"590_CR125","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.3748\/wjg.v21.i11.3206","volume":"21","author":"Y Murayama","year":"2015","unstructured":"Murayama Y, Oritani K, Tsutsui S. Novel CD9-targeted therapies in gastric cancer. World J Gastroenterol WJG. 2015;21:3206.","journal-title":"World J Gastroenterol WJG"},{"key":"590_CR126","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00535-009-0081-3","volume":"44","author":"T Nakamoto","year":"2009","unstructured":"Nakamoto T, Murayama Y, Oritani K, Boucheix C, Rubinstein E, Nishida M, et al. A novel therapeutic strategy with anti-CD9 antibody in gastric cancers. J Gastroenterol. 2009;44:889\u201396.","journal-title":"J Gastroenterol"},{"key":"590_CR127","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1365-2141.1990.tb02568.x","volume":"74","author":"RE Worthington","year":"1990","unstructured":"Worthington RE, Carroll RC, Boucheix C. Platelet activation by CD9 monoclonal antibodies is mediated by the Fc gamma II receptor. Br J Haematol. 1990;74:216\u201322.","journal-title":"Br J Haematol"},{"key":"590_CR128","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1182\/blood-2019-127894","volume":"134","author":"G De Jong","year":"2019","unstructured":"De Jong G, Levie SE, Schotte R, Pos W, Go D, Yasuda E, et al. AT1412, a patient-derived antibody in development for the treatment of CD9 positive precursor B-acute lymphoblastic leukemia. Blood. 2019;134:4461.","journal-title":"Blood"},{"key":"590_CR129","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1182\/blood-2020-134088","volume":"136","author":"R Schotte","year":"2020","unstructured":"Schotte R, Villaudy J, De Jong G, Neviani V, Pos W, Levie SE, et al. Preclinical development of AT1412, a patient derived CD9 antibody that does not induce thrombosis for treatment of B ALL. Blood. 2020;136:41\u20132.","journal-title":"Blood"},{"key":"590_CR130","doi-asserted-by":"publisher","first-page":"S493","DOI":"10.1016\/j.annonc.2020.08.696","volume":"31","author":"Villaudy","year":"2020","unstructured":"Villaudy, Schotte J, Jong R, de G, Neviani V, Pos W, et al. 582P Preclinical development of AT1412, a patient derived CD9 antibody that does not induce thrombosis for treatment of precursor B ALL. Ann Oncol. 2020;31:S493.","journal-title":"Ann Oncol"},{"key":"590_CR131","unstructured":"Kling Biotherapeutics B.V. A Phase I, First-in-human, Multicenter, Open-label, Dose Escalation Followed by an Expansion Phase Clinical Study of KBA1412 Given as Monotherapy or in Combination With Pembrolizumab in Adults With Advanced Solid Malignant Tumors. clinicaltrials.gov; 2024. Report No.: NCT05501821. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05501821"},{"key":"590_CR132","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/sj.onc.1206106","volume":"22","author":"T Funakoshi","year":"2003","unstructured":"Funakoshi T, Tachibana I, Hoshida Y, Kimura H, Takeda Y, Kijima T, et al. Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer. Oncogene. 2003;22:674\u201387.","journal-title":"Oncogene"},{"key":"590_CR133","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/jcp.21384","volume":"216","author":"Y Murayama","year":"2008","unstructured":"Murayama Y, Shinomura Y, Oritani K, Miyagawa JI, Yoshida H, Nishida M, et al. The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells. J Cell Physiol. 2008;216:135\u201343.","journal-title":"J Cell Physiol"},{"key":"590_CR134","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.3390\/ijms24032676","volume":"24","author":"E Blanco","year":"2023","unstructured":"Blanco E, Chocarro L, Fern\u00e1ndez-Rubio L, Bocanegra A, Arasanz H, Echaide M, et al. Leading edge: intratumor delivery of monoclonal antibodies for the treatment of solid tumors. Int J Mol Sci. 2023;24:2676.","journal-title":"Int J Mol Sci"},{"key":"590_CR135","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.3390\/cells11162474","volume":"11","author":"MF Santos","year":"2022","unstructured":"Santos MF, Rappa G, Fontana S, Karbanov\u00e1 J, Aalam F, Tai D, et al. Anti-human CD9 Fab fragment antibody blocks the extracellular vesicle-mediated increase in malignancy of colon cancer cells. Cells. 2022;11:2474.","journal-title":"Cells"},{"key":"590_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2023.213283","volume":"146","author":"T Suwatthanarak","year":"2023","unstructured":"Suwatthanarak T, Ito K, Tanaka M, Sugiura K, Hoshino A, Miyamoto Y, et al. A peptide binding to the tetraspanin CD9 reduces cancer metastasis. Biomater Adv. 2023;146:213283.","journal-title":"Biomater Adv"},{"key":"590_CR137","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3390\/molecules27020536","volume":"27","author":"AM Quemener","year":"2022","unstructured":"Quemener AM, Centomo ML, Sax SL, Panella R. Small drugs, huge impact: the extraordinary impact of antisense oligonucleotides in research and drug development. Molecules. 2022;27:536.","journal-title":"Molecules"},{"key":"590_CR138","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1594","volume":"11","author":"AM Quemener","year":"2020","unstructured":"Quemener AM, Bachelot L, Forestier A, Donnou-Fournet E, Gilot D, Galibert MD. The powerful world of antisense oligonucleotides: from bench to bedside. Wiley Interdiscip Rev RNA. 2020;11:e1594.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"590_CR139","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","volume":"19","author":"TC Roberts","year":"2020","unstructured":"Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020;19:673\u201394. Oct.","journal-title":"Nat Rev Drug Discov"},{"key":"590_CR140","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1093\/nar\/gkad415","volume":"51","author":"B Malecova","year":"2023","unstructured":"Malecova B, Burke RS, Cochran M, Hood MD, Johns R, Kovach PR, et al. Targeted tissue delivery of RNA therapeutics using antibody\u2013oligonucleotide conjugates (AOCs). Nucleic Acids Res. 2023;51:5901\u201310.","journal-title":"Nucleic Acids Res"},{"key":"590_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-65623-y","volume":"14","author":"S Biagiotti","year":"2024","unstructured":"Biagiotti S, Canonico B, Tiboni M, Abbas F, Perla E, Montanari M, et al. Efficient and highly reproducible production of red blood cell-derived extracellular vesicle mimetics for the loading and delivery of RNA molecules. Sci Rep. 2024;14:14610.","journal-title":"Sci Rep"},{"key":"590_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122074","volume":"625","author":"C Yan","year":"2022","unstructured":"Yan C, Gu J, Zhang Y, Ma K, Lee RJ. Efficient delivery of the Bcl-2 antisense oligonucleotide G3139 via nucleus-targeted aCD33-NKSN nanoparticles. Int J Pharm. 2022;625:122074.","journal-title":"Int J Pharm"},{"key":"590_CR143","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/cgt.2016.33","volume":"23","author":"MA Zaimy","year":"2016","unstructured":"Zaimy MA, Jebali A, Bazrafshan B, Mehrtashfar S, Shabani S, Tavakoli A, et al. Coinhibition of overexpressed genes in acute myeloid leukemia subtype M2 by gold nanoparticles functionalized with five antisense oligonucleotides and one anti-CD33(+)\/CD34(+) aptamer. Cancer Gene Ther. 2016;23:315\u201320. Sep.","journal-title":"Cancer Gene Ther"},{"key":"590_CR144","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13255","volume":"55","author":"H Chen","year":"2022","unstructured":"Chen H, Jayasinghe MK, Yeo EYM, Wu Z, Pirisinu M, Usman WM, et al. CD33-targeting extracellular vesicles deliver antisense oligonucleotides against FLT3-ITD and miR-125b for specific treatment of acute myeloid leukaemia. Cell Prolif. 2022;55:e13255.","journal-title":"Cell Prolif"},{"key":"590_CR145","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10585-005-4417-y","volume":"22","author":"K Mimori","year":"2005","unstructured":"Mimori K, Kataoka A, Yoshinaga K, Ohta M, Sagara Y, Yoshikawa Y, et al. Identification of molecular markers for metastasis-related genes in primary breast cancer cells. Clin Exp Metastasis. 2005;22:59\u201367.","journal-title":"Clin Exp Metastasis"},{"key":"590_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104991","volume":"159","author":"LJ Zhao","year":"2020","unstructured":"Zhao LJ, Fan QQ, Li YY, Ren HM, Zhang T, Liu S, et al. LSD1 deletion represses gastric cancer migration by upregulating a novel miR-142-5p target protein CD9. Pharmacol Res. 2020;159:104991.","journal-title":"Pharmacol Res"},{"key":"590_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2479-z","volume":"11","author":"Y Li","year":"2020","unstructured":"Li Y, Yu S, Li L, Chen J, Quan M, Li Q, et al. KLF4-mediated upregulation of CD9 and CD81 suppresses hepatocellular carcinoma development via JNK signaling. Cell Death Dis. 2020;11:299.","journal-title":"Cell Death Dis"},{"key":"590_CR148","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1038\/sj.leu.2404343","volume":"20","author":"E De Bruyne","year":"2006","unstructured":"De Bruyne E, Andersen TL, De Raeve H, Van Valckenborgh E, Caers J, Van Camp B, et al. Endothelial cell-driven regulation of CD9 or motility-related protein-1 expression in multiple myeloma cells within the murine 5T33MM model and myeloma patients. Leukemia. 2006;20:1870\u20139.","journal-title":"Leukemia"},{"key":"590_CR149","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1158\/0008-5472.CAN-06-3090","volume":"67","author":"T Takeda","year":"2007","unstructured":"Takeda T, Hattori N, Tokuhara T, Nishimura Y, Yokoyama M, Miyake M. Adenoviral transduction of MRP-1\/CD9 and KAI1\/CD82 inhibits lymph node metastasis in orthotopic lung cancer model. Cancer Res. 2007;67:1744\u20139.","journal-title":"Cancer Res"},{"key":"590_CR150","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.1158\/0008-5472.CAN-05-4478","volume":"66","author":"N Oku","year":"2006","unstructured":"Oku N, Sasabe E, Ueta E, Yamamoto T, Osaki T. Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res. 2006;66:5251\u20137.","journal-title":"Cancer Res"},{"key":"590_CR151","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27180-z","volume":"8","author":"JS Brzozowski","year":"2018","unstructured":"Brzozowski JS, Bond DR, Jankowski H, Goldie BJ, Burchell R, Naudin C, et al. Extracellular vesicles with altered tetraspanin CD9 and CD151 levels confer increased prostate cell motility and invasion. Sci Rep. 2018;8:8822.","journal-title":"Sci Rep"},{"key":"590_CR152","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1365-2605.2005.00552.x","volume":"28","author":"Y Chuan","year":"2005","unstructured":"Chuan Y, Pang ST, Bergh A, Norstedt G, Pousette A. Androgens induce CD-9 in human prostate tissue. Int J Androl. 2005;28:291\u20136.","journal-title":"Int J Androl"},{"key":"590_CR153","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/ijc.28204","volume":"133","author":"BT Copeland","year":"2013","unstructured":"Copeland BT, Bowman MJ, Boucheix C, Ashman LK. Knockout of the tetraspanin Cd9 in the TRAMP model of de novo prostate cancer increases spontaneous metastases in an organ-specific manner. Int J Cancer. 2013;133:1803\u201312.","journal-title":"Int J Cancer"},{"key":"590_CR154","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/BF02966685","volume":"5","author":"K Arihiro","year":"1998","unstructured":"Arihiro K, Kaneko M, Fujii S, Inai K. Loss of CD9 with expression of CD31 and VEGF in breast carcinoma, as predictive factors of lymph node metastasis. Breast Cancer. 1998;5:131\u20138.","journal-title":"Breast Cancer"},{"key":"590_CR155","first-page":"4127","volume":"55","author":"M Miyake","year":"1995","unstructured":"Miyake M, Nakano K, Ieki Y, Adachi M, Huang CL, Itoi S, et al. Motility related protein 1 (MRP-1\/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res. 1995;55:4127\u201331.","journal-title":"Cancer Res"},{"key":"590_CR156","first-page":"6426","volume":"9","author":"G Sauer","year":"2003","unstructured":"Sauer G, Windisch J, Kurzeder C, Heilmann V, Kreienberg R, Deissler H. Progression of cervical carcinomas is associated with down-regulation of CD9 but strong local re-expression at sites of transendothelial invasion. Clin Cancer Res J Am Assoc Cancer Res. 2003;9:6426\u201331.","journal-title":"Clin Cancer Res J Am Assoc Cancer Res"},{"key":"590_CR157","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/sj.bjc.6601015","volume":"89","author":"H Hashida","year":"2003","unstructured":"Hashida H, Takabayashi A, Tokuhara T, Hattori N, Taki T, Hasegawa H, et al. Clinical significance of transmembrane 4 superfamily in colon cancer. Br J Cancer. 2003;89:158\u201367.","journal-title":"Br J Cancer"},{"key":"590_CR158","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4132\/jptm.2016.10.02","volume":"50","author":"KJ Kim","year":"2016","unstructured":"Kim KJ, Kwon HJ, Kim MC, Bae YK. CD9 expression in colorectal carcinomas and its prognostic significance. J Pathol Transl Med. 2016;50:459\u201368.","journal-title":"J Pathol Transl Med"},{"key":"590_CR159","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.3390\/ijms23094775","volume":"23","author":"G Lucarini","year":"2022","unstructured":"Lucarini G, Molinelli E, Licini C, Rizzetto G, Radi G, Goteri G, et al. Tetraspanin CD9 expression predicts sentinel node status in patients with cutaneous melanoma. Int J Mol Sci. 2022;23:4775.","journal-title":"Int J Mol Sci"},{"key":"590_CR160","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/1097-0142(20010801)92:3<542::AID-CNCR1353>3.0.CO;2-8","volume":"92","author":"S Miyamoto","year":"2001","unstructured":"Miyamoto S, Maruyama A, Okugawa K, Akazawa K, Baba H, Maehara Y, et al. Loss of motility-related protein 1 (MRP1\/CD9) and integrin alpha3 expression in endometrial cancers. Cancer. 2001;92:542\u20138.","journal-title":"Cancer"},{"key":"590_CR161","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/sj.bjc.6690186","volume":"79","author":"S Uchida","year":"1999","unstructured":"Uchida S, Shimada Y, Watanabe G, Li ZG, Hong T, Miyake M, et al. Motility-related protein (MRP-1\/CD9) and KAI1\/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer. 1999;79:1168\u201373.","journal-title":"Br J Cancer"},{"key":"590_CR162","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1477-7819-10-92","volume":"10","author":"Q Zou","year":"2012","unstructured":"Zou Q, Xiong L, Yang Z, Lv F, Yang L, Miao X. Expression levels of HMGA2 and CD9 and its clinicopathological significances in the benign and malignant lesions of the gallbladder. World J Surg Oncol. 2012;10:92.","journal-title":"World J Surg Oncol"},{"key":"590_CR163","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.prp.2010.04.004","volume":"206","author":"S Soyuer","year":"2010","unstructured":"Soyuer S, Soyuer I, Unal D, Ucar K, Yildiz OG, Orhan O. Prognostic significance of CD9 expression in locally advanced gastric cancer treated with surgery and adjuvant chemoradiotherapy. Pathol Res Pract. 2010;206:607\u201310.","journal-title":"Pathol Res Pract"},{"key":"590_CR164","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/bjc.2017.487","volume":"118","author":"Y Miki","year":"2018","unstructured":"Miki Y, Yashiro M, Okuno T, Kitayama K, Masuda G, Hirakawa K, et al. CD9-positive exosomes from cancer-associated fibroblasts stimulate the migration ability of scirrhous-type gastric cancer cells. Br J Cancer. 2018;118:867\u201377.","journal-title":"Br J Cancer"},{"key":"590_CR165","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ijc.2910540107","volume":"54","author":"Z Si","year":"1993","unstructured":"Si Z, Hersey P. Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely related to metastatic potential of melanoma. Int J Cancer. 1993;54:37\u201343.","journal-title":"Int J Cancer"},{"key":"590_CR166","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3892\/or.2012.2116","volume":"29","author":"VJ Amatya","year":"2013","unstructured":"Amatya VJ, Takeshima Y, Aoe K, Fujimoto N, Okamoto T, Yamada T, et al. CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma. Oncol Rep. 2013;29:21\u20138.","journal-title":"Oncol Rep"},{"key":"590_CR167","doi-asserted-by":"publisher","first-page":"e86671","DOI":"10.1371\/journal.pone.0086671","volume":"9","author":"T Okamoto","year":"2014","unstructured":"Okamoto T, Iwata S, Yamazaki H, Hatano R, Komiya E, Dang NH, et al. CD9 negatively regulates CD26 expression and inhibits CD26-mediated enhancement of invasive potential of malignant mesothelioma cells. PLoS ONE. 2014;9:e86671.","journal-title":"PLoS ONE"},{"key":"590_CR168","first-page":"6040","volume":"55","author":"M Higashiyama","year":"1995","unstructured":"Higashiyama M, Taki T, Ieki Y, Adachi M, Huang CL, Koh T, et al. Reduced motility related protein-1 (MRP-1\/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res. 1995;55:6040\u20134.","journal-title":"Cancer Res"},{"key":"590_CR169","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1200\/JCO.1998.16.4.1397","volume":"16","author":"M Adachi","year":"1998","unstructured":"Adachi M, Taki T, Konishi T, Huang CI, Higashiyama M, Miyake M. Novel staging protocol for non-small-cell lung cancers according to MRP-1\/CD9 and KAI1\/CD82 gene expression. J Clin Oncol J Am Soc Clin Oncol. 1998;16:1397\u2013406.","journal-title":"J Clin Oncol J Am Soc Clin Oncol"},{"key":"590_CR170","doi-asserted-by":"publisher","first-page":"8025","DOI":"10.1158\/0008-5472.CAN-10-0996","volume":"70","author":"S Kohmo","year":"2010","unstructured":"Kohmo S, Kijima T, Otani Y, Mori M, Minami T, Takahashi R, et al. Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer. Cancer Res. 2010;70:8025\u201335.","journal-title":"Cancer Res"},{"key":"590_CR171","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.oraloncology.2009.11.009","volume":"46","author":"MEC Buim","year":"2010","unstructured":"Buim MEC, Louren\u00e7o SV, Carvalho KC, Cardim R, Pereira C, Carvalho AL, et al. Downregulation of CD9 protein expression is associated with aggressive behavior of oral squamous cell carcinoma. Oral Oncol. 2010;46:166\u201371.","journal-title":"Oral Oncol"},{"key":"590_CR172","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1034\/j.1600-0714.2001.300202.x","volume":"30","author":"J Kusukawa","year":"2001","unstructured":"Kusukawa J, Ryu F, Kameyama T, Mekada E. Reduced expression of CD9 in oral squamous cell carcinoma: CD9 expression inversely related to high prevalence of lymph node metastasis. J Oral Pathol Med. 2001;30:73\u20139.","journal-title":"J Oral Pathol Med"},{"key":"590_CR173","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1006\/gyno.2002.6729","volume":"86","author":"CD Houle","year":"2002","unstructured":"Houle CD, Ding XY, Foley JF, Afshari CA, Barrett JC, Davis BJ. Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian cancer progression. Gynecol Oncol. 2002;86:69\u201378.","journal-title":"Gynecol Oncol"},{"key":"590_CR174","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24517","volume":"36","author":"X Han","year":"2022","unstructured":"Han X, Zhang WH, Gao HL, Li TJ, Xu HX, Li H, et al. Neoadjuvant chemotherapy endows CD9 with prognostic value that differs between tumor and stromal areas in patients with pancreatic cancer. J Clin Lab Anal. 2022;36:e24517.","journal-title":"J Clin Lab Anal"},{"key":"590_CR175","doi-asserted-by":"publisher","first-page":"695","DOI":"10.21037\/jgo.2018.07.02","volume":"10","author":"M Khushman","year":"2019","unstructured":"Khushman M, Patel GK, Laurini JA, Bhardwaj A, Roveda K, Donnell R, et al. Exosomal markers (CD63 and CD9) expression and their prognostic significance using immunohistochemistry in patients with pancreatic ductal adenocarcinoma. J Gastrointest Oncol. 2019;10:695\u2013702.","journal-title":"J Gastrointest Oncol"},{"key":"590_CR176","doi-asserted-by":"publisher","first-page":"224","DOI":"10.5603\/EP.a2019.0009","volume":"70","author":"T Kim","year":"2019","unstructured":"Kim T, Kim Y, Kwon HJ. Expression of CD9 and CD82 in papillary thyroid microcarcinoma and its prognostic significance. Endokrynol Pol. 2019;70:224\u201331.","journal-title":"Endokrynol Pol"},{"key":"590_CR177","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11596-007-0123-0","volume":"27","author":"X Ai","year":"2007","unstructured":"Ai X, Zhang X, Wu Z, Ma X, Ju Z, Wang B, et al. Expression of KAI1\/CD82 and MRP-1\/CD9 in transitional cell carcinoma of bladder. J Huazhong Univ Sci Technol Med Sci. 2007;27:79\u201382.","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"key":"590_CR178","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/cncr.11698","volume":"98","author":"P Mhawech","year":"2003","unstructured":"Mhawech P, Herrmann F, Coassin M, Guillou L, Iselin CE. Motility-related protein 1 (MRP-1\/CD9) expression in urothelial bladder carcinoma and its relation to tumor recurrence and progression. Cancer. 2003;98:1649\u201357.","journal-title":"Cancer"}],"container-title":["Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41389-025-00590-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-025-00590-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-025-00590-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T20:02:56Z","timestamp":1764964976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41389-025-00590-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":178,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["590"],"URL":"https:\/\/doi.org\/10.1038\/s41389-025-00590-1","relation":{},"ISSN":["2157-9024"],"issn-type":[{"value":"2157-9024","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors consent to publication of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"47"}}